Lineage Cell Therapeutics Inc. (LCTX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Broadwood Capital

Neal C. Bradsher

34,935,485 $38,079,679 3.24%
2. 587,429 $640,297 +48% 0%
3. 433,748 $472,785 -62% 0%
4.
Millennium Management

Israel Englander

57,998 $63,218 0%
5.
Two Sigma Advisors

John Overdeck And David Siegel

37,900 $41,311 -4% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.04 96,155 Director 158,801 2024-02-08 Filing
$0.00 0 Large Shareholder, Director 41,666,255 2024-02-06 Filing
$1.04 6,730,770 Large Shareholder, Director 41,666,255 2024-02-06 Filing
$1.09 10,000 Director 10,000 2023-12-29 Filing
$1.53 6,400 Officer, Director 97,787 2022-03-31 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.44 28,445 Officer 0 2021-12-29 Filing
$2.49 9,250 Officer 28,445 2021-12-29 Filing
$2.45 501,588 Officer 28,445 2021-12-28 Filing
$2.93 19,142 Director 15,578 2021-06-29 Filing
$2.97 4,720 Director 87,500 2021-06-29 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 8,531,498 $9,299,332 0%
2. 8,384,687 $9,139,309 0%
3. 4,969,675 $5,416,946 1.9%
4. 2,935,811 $3,200,483 0%
5. 2,131,621 $2,323,467 2.93%
News See All